美国动物遗传学市场规模、份额和趋势分析报告：按动物、类型、分销管道和细分市场预测，2025-2033 年

美国动物遗传学市场摘要

预计 2024 年美国动物遗传学市场价值将达到 19.4 亿美元，到 2033 年将达到 31.9 亿美元，2025 年至 2033 年的复合年增长率为 5.83%。

推动市场成长的因素包括兽医遗传学研究的进步、大规模兽医遗传学计划的出现、动物育种应用的扩大以及兽医遗传学培训和教育的加强。

动物遗传学的进步显着推动了美国市场的成长，因为它提高了抗病能力、育种精准度并完善了合作研究基础设施。由犹他州立大学主导、美国农业部于2024年12月资助的合作研究网络将获得超过325万美元的资助，用于促进跨机构和多学科的基因序列测定、数位DNA表达和牲畜（包括牛、羊、猪、鸡和鱼）精准育种方面的研究，最终支持提高生产力、抗病能力、应对气候变迁的能力和粮食安全。

与此相辅相成的是，加州大学戴维斯分校于2025年3月成立的「有意基因组改造创新中心」（一项由FDA支持的计划）旨在推进包括猪、羊和牛在内的牲畜物种的基因组编辑，其目标包括改善动物健康、提高生产力，并为基因编辑食用动物建立明智的、基于科学的法律规范。同时，在基因编辑的实践方面，研究人员正在积极部署DNA编辑技术，引入有益性状，例如天然偏好（无蹄）动物和增强的抗病性，以增强牲畜生物安全，并符合消费者偏好和福利标准。

从雄厚的资金筹措、合作基础设施到标靶基因编辑技术，这些发展正在支持基因组工具在农业领域的大规模部署。这些发展正在加速创新研究向商业性化解决方案的转化，并推动对基因检测、育种服务和基因编辑应用的需求，从而扩大市场。

遗传工具在动物育种中日益广泛的使用，使得畜牧业发展更加精准、高效和永续，推动了美国动物遗传学产业的发展。根据遗传素养计划，利用个体之间的微小遗传差异（甚至小于 1%）可以培育出经济效益、环境復原力和社会永续性均优化的牲畜。

同时，德克萨斯农工大学新成立的比较基因组学中心获得了数百万美元的机构资金支持，使其成为动物遗传学跨学科研究的中心，推动了性状改良、抗病性以及农业和生物医学应用领域的创新。这些新兴市场利用基因组学知识和机构能力的发展，正在推动市场扩张，加速将研究成果转化为商业性育种服务、基因检测和先进的基因组学解决方案，从而改变美国各地的畜牧业。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国动物遗传学市场趋势与展望

• 市场体系展望
  • 母市场
  • 子公司市场
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 市场机会分析
  • 市场问题分析
• 美国动物遗传市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析
  • 法律规范
  • 技术演进分析
  • 2024年定价分析
  • 2024年主要物种和国家动物族群数量估计

第四章美国动物遗传学市场：动物估计与趋势分析

• 细分仪表板
• 美国动物遗传学市场：动物变异分析
• 美国动物遗传学市场规模与趋势分析（按物种，2021-2033 年）
• 牛
• 猪
• 绵羊和山羊
• 伴侣动物
• 其他的

第五章美国动物遗传学市场：类型估计和趋势分析

• 细分仪表板
• 美国动物遗传学市场：类型变异分析
• 美国动物遗传学市场规模与趋势分析（2021-2033）
• 辅助生殖技术
• 活体动物
• 基因组/基因检测

第六章：美国动物遗传学市场：通路评估与趋势分析

• 细分仪表板
• 美国动物遗传学市场：分销管道波动分析
• 美国动物遗传学市场规模及趋势分析（按分销管道）（2021-2033）
  • 私人的
  • 公共

第七章 竞争态势

• 市场参与企业分类
• 企业市场分析/热图分析
• 公司简介
  • Neogen Corporation
  • Genetics Australia
  • Hendrix Genetics BV
  • URUS Group LP
  • CRV
  • Semex
  • Swine Genetics International
  • STgenetics
  • Animal Genetics Inc.
  • Select Sires Inc.
  • Zoetis Services LLC
  • Genus plc
• 战略地图
  • 併购
  • 伙伴关係与合作
  • 产品发布
  • 其他的
• 其他主要参与者名单

U.S. Animal Genetics Market Summary

The U.S. animal genetics market size was estimated at USD 1.94 billion in 2024 and is projected to reach USD 3.19 billion by 2033, growing at a CAGR of 5.83% from 2025 to 2033. Some of the factors driving the market growth are advancements in veterinary genetic research, emerging large-scale veterinary genetics projects, growing application in animal breeding, and increasing veterinary genetics training and education.

Advancements in animal genetics are significantly propelling growth in the U.S. market by enhancing disease resilience, breeding precision, and collaborative research infrastructure. A December 2024 USDA-funded collaboration network led by Utah State University, backed by more than USD 3.25 million, is fostering cross-institutional and interdisciplinary research in genome sequencing, digital DNA representations, and precision breeding across livestock such as cattle, sheep, pigs, poultry, and fish-ultimately supporting improvements in productivity, disease resistance, climate resilience, and food security.

Complementing this, UC Davis's March 2025 established Intentional Genomic Alteration Innovation Center (under an FDA-supported initiative) aims to advance genome editing across livestock like pigs, sheep, and cattle, with goals including improved animal health, productivity, and enabling well-informed, science-based regulatory frameworks for gene-edited food animals. Meanwhile, on the practical side of gene editing, researchers are actively deploying DNA-editing techniques to introduce beneficial traits such as naturally hornless (polled) animals and enhanced disease resistance-efforts that not only align with consumer preferences and welfare standards but also strengthen livestock biosecurity.

Cumulatively, these developments-from robust funding and collaborative infrastructure to targeted gene editing technologies-are underpinning larger-scale deployment of genomic tools in agriculture. Together, they drive market expansion by accelerating the translation of innovative research into commercially viable solutions, catalyzing demand for genetic testing, breeding services, and gene-editing applications.

The expanding use of genetic tools in animal breeding is propelling the growth of the U.S. animal genetics industry by enabling far more precise, efficient, and sustainable livestock development. According to the Genetic Literacy Project, exploiting the tiny genetic differences-even those under 1%-between individual animals makes it possible to breed animals optimized for economic performance, environmental resilience, and social sustainability; this precision elevates breeding programs from art to high-impact science.

Concurrently, the establishment of Texas A&M's new Center for Comparative Genomics-backed by millions in institutional funding-positions the university as a hub for interdisciplinary research in animal genetics, fostering innovations in trait improvement, disease resistance, and translational applications across agriculture and biomedicine. Together, these developments-leveraging genomic insights and institutional capacity-are driving market expansion by accelerating the translation of research into commercial breeding services, genetic testing, and advanced genomic solutions that are transforming livestock production across the U.S.

U.S. Animal Genetics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. animal genetics market report based on animal, type, and distribution channel:

• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Cattle
• Pigs
• Sheep & Goats
• Companion Animals
• Others
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Assistive Reproduction Technologies
• Live Animals
• Genomic/Genetic Testing
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Private
• Public

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Country Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Animal Genetics Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Advancements in Veterinary Genetic Research
    • 3.2.1.2. Emerging Large Scale Veterinary Genetics Projects
    • 3.2.1.3. Growing Application in Animal Breeding
    • 3.2.1.4. Increasing Veterinary Genetics Training and Education
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of advanced genetic technologies and services
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. U.S. Animal Genetics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Technology Evolution Analysis
  • 3.3.5. Pricing Analysis, 2024
  • 3.3.6. Estimated Animal Population, by key species & key countries, 2024

Chapter 4. U.S. Animal Genetics Market: Animal Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Animal Genetics Market: Animal Movement Analysis
• 4.3. U.S. Animal Genetics Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
• 4.4. Cattle
  • 4.4.1. Cattle Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Pigs
  • 4.5.1. Pigs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Sheep & Goat
  • 4.6.1. Sheep & Goat Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Companion Animals
  • 4.7.1. Companion Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Animal Genetics Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Animal Genetics Market: Type Movement Analysis
• 5.3. U.S. Animal Genetics Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 5.4. Assistive Reproduction Technologies
  • 5.4.1. Assistive Reproduction Technologies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Live Animals
  • 5.5.1. Live Animals Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Genomic/Genetics Testing
  • 5.6.1. Genomic/Genetics Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Animal Genetics Market: By Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Animal Genetics Market: By Distribution Channel Movement Analysis
• 6.3. U.S. Animal Genetics Market Size & Trend Analysis, by Distribution Channel 2021 to 2033 (USD Million)
  • 6.3.1. Private
    • 6.3.1.1. Private Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Public
    • 6.3.2.1. Public Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Company Market Position Analysis/ Heat Map Analysis
• 7.3. Company Profiles
  • 7.3.1. Neogen Corporation
    • 7.3.1.1. Participant's Overview
    • 7.3.1.2. Financial Performance
    • 7.3.1.3. Product Benchmarking
    • 7.3.1.4. Strategic Initiatives
  • 7.3.2. Genetics Australia
    • 7.3.2.1. Participant's Overview
    • 7.3.2.2. Financial Performance
    • 7.3.2.3. Product Benchmarking
    • 7.3.2.4. Strategic Initiatives
  • 7.3.3. Hendrix Genetics BV
    • 7.3.3.1. Participant's Overview
    • 7.3.3.2. Financial Performance
    • 7.3.3.3. Product Benchmarking
    • 7.3.3.4. Strategic Initiatives
  • 7.3.4. URUS Group LP
    • 7.3.4.1. Participant's Overview
    • 7.3.4.2. Financial Performance
    • 7.3.4.3. Product Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. CRV
    • 7.3.5.1. Participant's Overview
    • 7.3.5.2. Financial Performance
    • 7.3.5.3. Product Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. Semex
    • 7.3.6.1. Participant's Overview
    • 7.3.6.2. Financial Performance
    • 7.3.6.3. Product Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. Swine Genetics International
    • 7.3.7.1. Participant's Overview
    • 7.3.7.2. Financial Performance
    • 7.3.7.3. Product Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. STgenetics
    • 7.3.8.1. Participant's Overview
    • 7.3.8.2. Financial Performance
    • 7.3.8.3. Product Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. Animal Genetics Inc.
    • 7.3.9.1. Participant's Overview
    • 7.3.9.2. Financial Performance
    • 7.3.9.3. Product Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. Select Sires Inc.
    • 7.3.10.1. Participant's Overview
    • 7.3.10.2. Financial Performance
    • 7.3.10.3. Product Benchmarking
    • 7.3.10.4. Strategic Initiatives
  • 7.3.11. Zoetis Services LLC
    • 7.3.11.1. Participant's Overview
    • 7.3.11.2. Financial Performance
    • 7.3.11.3. Product Benchmarking
    • 7.3.11.4. Strategic Initiatives
  • 7.3.12. Genus plc
    • 7.3.12.1. Participant's Overview
    • 7.3.12.2. Financial Performance
    • 7.3.12.3. Product Benchmarking
    • 7.3.12.4. Strategic Initiatives
• 7.4. Strategy Mapping
  • 7.4.1. Mergers & Acquisitions
  • 7.4.2. Partnerships & Collaborations
  • 7.4.3. Product launch
  • 7.4.4. Others
• 7.5. List of other key players

List of Tables

• Table 1 List of secondary sources
• Table 2 U.S. Animal Genetics Market, by Animal, 2021 - 2033 (USD Million)
• Table 3 U.S. Animal Genetics Market, by Type, 2021 - 2033 (USD Million)
• Table 4 U.S. Animal Genetics Market, by Distribution Channel, 2021 - 2033 (USD Million)
• Table 5 Company Overview
• Table 6 Product Benchmarking
• Table 7 Financial Performance
• Table 8 Strategic Initiatives

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. Animal Genetics Market revenue, 2021-2033 (USD Million)
• Fig. 10 U.S. Animal Genetics Market snapshot
• Fig. 11 U.S. Animal Genetics Market driver impact
• Fig. 12 U.S. Animal Genetics Market restraint impact
• Fig. 13 U.S. Animal Genetics animal key takeaways (USD Million)
• Fig. 14 U.S. Animal Genetics Market: animal, market share 2024 & 2033
• Fig. 15 Cattle market, 2021 - 2033 (USD Million)
• Fig. 16 Pigs Animals market, 2021 - 2033 (USD Million)
• Fig. 17 Sheep & Goat market, 2021 - 2033 (USD Million)
• Fig. 18 Companion animals market, 2021 - 2033 (USD Million)
• Fig. 19 Others market, 2021 - 2033 (USD Million)
• Fig. 20 Animal Genetics Market type key takeaways (USD Million)
• Fig. 21 Animal Genetics Market: type, market share 2024 & 2033
• Fig. 22 Assistive Reproduction Technologies market, 2021 - 2033 (USD Million)
• Fig. 23 Live animals market, 2021 - 2033 (USD Million)
• Fig. 24 Genomic/genetic testing market, 2021 - 2033 (USD Million)
• Fig. 25 Animal Genetics market by distribution channel: Key takeaways
• Fig. 26 Animal Genetics market by distribution channel, market share, 2024 & 2033
• Fig. 27 Private market, 2021 - 2033 (USD Million)
• Fig. 28 Public market, 2021 - 2033 (USD Million)
• Fig. 29 Market participant categorization